These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

56 related articles for article (PubMed ID: 2984796)

  • 1. Reactivity of Bushman sera with HTLV-III--what does it mean?
    de St J van der Riet F; Hesseling PB
    S Afr Med J; 1985 Apr; 67(16):617-8. PubMed ID: 2984796
    [No Abstract]   [Full Text] [Related]  

  • 2. Unique pattern of HTLV-III (AIDS-related) antigen recognition by sera from African children in Uganda (1972).
    Saxinger C; Levine PH; Dean A; Lange-Wantzin G; Gallo R
    Cancer Res; 1985 Sep; 45(9 Suppl):4624s-4626s. PubMed ID: 2990697
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Anti-LAV/HTLV-III antibodies in gamma globulin preparations destined for intravenous administration].
    Dickgiesser N; Brenner KP; Mertens T
    Dtsch Med Wochenschr; 1986 Jun; 111(26):1041. PubMed ID: 3013564
    [No Abstract]   [Full Text] [Related]  

  • 4. [Prevalence of antibodies against HTLV-III in various regions in Switzerland].
    Schüpbach J; Vogt M; Bhushan R; Lüthy R; Haller O; Joller H; Ferber T; Büchner S; Schuppli R; Schädelin J
    Schweiz Med Wochenschr; 1985 Jul; 115(30):1048-54. PubMed ID: 2994208
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Increase in the prevalence of antibodies against LAV/HTLV III in drug addicts in West Germany].
    Zoulek G; Gürtler L; Eberle J; Lorbeer B; Deinhardt F
    Dtsch Med Wochenschr; 1986 Apr; 111(15):567-70. PubMed ID: 3007065
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased reactivity to HTLV-I in inflammatory nervous system diseases.
    Lolli F; Fredrikson S; Kam-Hansen S; Link H
    Ann Neurol; 1987 Jul; 22(1):67-71. PubMed ID: 2888429
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sero-epidemiology of HTLV-III antibody in southern Africa.
    Lyons SF; Schoub BD; McGillivray GM; Sher R
    S Afr Med J; 1985 Jun; 67(24):961-2. PubMed ID: 2988142
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Research on anti-HTLV-III antibodies: validity of methods].
    Achilli G; Cattaneo E
    Riv Emoter Immunoematol; 1985; 32(2):190-4. PubMed ID: 3003877
    [No Abstract]   [Full Text] [Related]  

  • 9. [Anti-HTLV-III/LAV antibodies in hematology reactives].
    Aznar JA; Monzó E; Mayans J; Granda D; Hurtado F; Curats R
    Sangre (Barc); 1986; 31(2):215-7. PubMed ID: 3014670
    [No Abstract]   [Full Text] [Related]  

  • 10. [HTLV-III antibodies and risk factors for healthy homosexuals in Zurich].
    Vogt M; Lüthy R; Ferber T; Ledergerber B; Schüpbach J; Täuber M; Siegenthaler W
    Schweiz Med Wochenschr; 1985 Dec; 115(49):1777-8. PubMed ID: 3003891
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Significance of anti-HTLV-III antibodies].
    Gerna G
    Riv Emoter Immunoematol; 1985; 32(2):195-7. PubMed ID: 3003878
    [No Abstract]   [Full Text] [Related]  

  • 12. HTLV antibodies in Italian patients with multiple sclerosis.
    Varmier O; Melioli G; Lillo F; Schito G; Repetto C; Ravegnani M; Battaglia M
    Ital J Neurol Sci; 1987 Jun; Suppl 6():51-2. PubMed ID: 2820895
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of HTLV-III antibodies and cellular immune status of hemophiliacs.
    Tsoukas C; Gervais F; Shuster J; Gold P; O'Shaughnessy M; Robert-Guroff M
    N Engl J Med; 1984 Dec; 311(23):1514-5. PubMed ID: 6095077
    [No Abstract]   [Full Text] [Related]  

  • 14. An indirect fluorescent antibody test for antibodies against HTLV-III.
    Sher R; Lyons S; dos Santos L; Schoub B; McGillivray G
    S Afr Med J; 1985 Mar; 67(10):357. PubMed ID: 2984791
    [No Abstract]   [Full Text] [Related]  

  • 15. [Usefulness of the determination of anti-HTLV-III antibodies in parenteral drug addicts].
    Forteza-Rei J; Altés J; Villalonga C; Riera M
    Med Clin (Barc); 1986 Apr; 86(14):610. PubMed ID: 3014238
    [No Abstract]   [Full Text] [Related]  

  • 16. [HTLV-III/LAV antibodies in gamma globulin preparations for intravenous use].
    Kaeser A
    Dtsch Med Wochenschr; 1986 Aug; 111(33):1263. PubMed ID: 2427300
    [No Abstract]   [Full Text] [Related]  

  • 17. [Immunofluorescence in the serological study of HTLV-III/LAV].
    Picchio G; Muchinik G
    Medicina (B Aires); 1986; 46(2):247-8. PubMed ID: 3033429
    [No Abstract]   [Full Text] [Related]  

  • 18. [Systematic detection of anti-LAV/HTLV-III antibodies in blood donors and hemophiliacs].
    Muncunill J; Forteza A; Forner N; Forteza-Rei J
    Med Clin (Barc); 1986 Apr; 86(13):565. PubMed ID: 3012224
    [No Abstract]   [Full Text] [Related]  

  • 19. Detection of antibody to HTLV-III by commercial kits.
    O'Shaughnessy MV; Benning BJ; Neumann PW
    CMAJ; 1985 Sep; 133(6):551, 555. PubMed ID: 2992733
    [No Abstract]   [Full Text] [Related]  

  • 20. [Prevalence of antibodies against LAV/HTLV-III in patients with terminal renal insufficiency treated with hemodialysis and following renal transplantation].
    Fassbinder W; Kühnl P; Neumayer HH; Offermann G; Seidl S; Schoeppe W
    Dtsch Med Wochenschr; 1986 Jul; 111(28-29):1087-90. PubMed ID: 3015545
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.